中超控股(002471.SZ):決定設立醫美投資決策諮詢委員會
格隆匯6月15日丨中超控股(002471.SZ)公佈,公司於2021年6月15日召開第五屆董事會第十次會議,審議通過《關於設立醫美投資決策諮詢委員會的議案》。
公司於2021年6月1日召開第五屆董事會第八次會議審議通過《關於參與設立醫療健康產業基金的議案》,於2021年6月15日召開第五屆董事會第十次會議審議通過《關於投資設立江蘇中超醫美健康投資管理有限公司的議案》,考慮到公司擬投資的醫療健康產業與公司現有電線電纜產業的差異性,為了降低公司跨行業投資的風險,提高投資回報,公司董事會決定設立醫美投資決策諮詢委員會,聘請具有醫療健康行業等管理經驗的專業人員為公司把控風險,整合和發揮各方優勢和資源,推進公司醫療健康板塊運作,培育公司新的利潤增長點。
根據《公司章程》有關規定,醫療健康產業相關議案需報公司相應決策機構審議或批准,審議決策前由此委員會提供建議和意見。
醫美投資決策諮詢委員會成員如下:主任:楊飛;首席顧問:王磊;副主任:陳洪兵、丁香;其他成員:曾令寰、楊毅、徐林虎、姚興江、吳燕、潘志娟、李川冰。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.